Matthew R Burns, MD, PhD
Assistant Professor Of Neurology
Department:
MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone:
(352) 294-5000
Business Email:
mburns1@ufl.edu
About Matthew R Burns
Matthew R. Burns, MD, PhD, is an assistant professor with the department of neurology at the University of Florida College of Medicine.
Dr. Burns received his medical degree and doctorate degree from the University of Illinois College of Medicine at Chicago. After doing an internal medicine internship at NorthShore University HealthSystem in Chicago, he completed his neurology residency at the University of Chicago Medical Center. He then pursued his movement disorders fellowship at the University of Florida.
Dr. Burns is board-certified in neurology by the American Board of Psychiatry and Neurology. In addition to being actively involved in various research projects, he serves as a lecturer for both the Parkinson’s Foundation and the Norman Fixel Institute for Neurological Diseases at UF Health. Dr. Burns has contributed to many publications, with his research interests including aging, deep brain stimulation, neurodegenerative disorders and bodily coordination.
His long-term career goal is to translate his knowledge of brain machine interface, electrophysiology, viral vectors and neurodegenerative diseases through extramural support into therapies for patients who have movement disorders and dementia.
Teaching Profile
Courses Taught
2022-2023
MDU4002 Introduction to Medical Science Seminar 2
2022-2023
PAS5020 Intro to Medicine 2
2022-2023
GMS6905 Independent Studies in Medical Sciences
Board Certifications
-
NeurologyAmerican Board of Psychiatry and Neurology
Clinical Profile
Specialties
- Neurology
Areas of Interest
- Acute cerebellar ataxia
- Deep brain stimulation
- Dystonia
- Essential tremor
- Friedreich ataxia
- Movement – uncontrollable
- Movement – uncontrolled or slow
- Movement – uncoordinated
- Movement – unpredictable or jerky
- Tremor disorders
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-9309-7723
Areas of Interest
- Deep brain stimulation
- Dementia
- Electrophysiology
- Neurodegenerative diseases
- ataxia
- mechanisms of aging
- neuromodulatory treatments
Publications
2022
Evolving Concepts in Our Understanding and Treatment of Holmes Tremor, Over 100 Years in the Making
Tremor and Other Hyperkinetic Movements.
12(1)
[DOI] 10.5334/tohm.683.
[PMID] 35651920.
2022
Inherited Ataxias in Children.
Pediatric neurology.
131:54-62
[DOI] 10.1016/j.pediatrneurol.2022.04.004.
[PMID] 35490578.
2022
Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease.
Brain communications.
4(4)
[DOI] 10.1093/braincomms/fcac165.
[PMID] 35822101.
2022
TANGO2 Mutation: A Genetic Cause of Multifocal Combined Dystonia.
Movement disorders clinical practice.
9(3):380-382
[DOI] 10.1002/mdc3.13400.
[PMID] 35402644.
2021
Advances and Future Directions of Neuromodulation in Neurologic Disorders.
Neurologic clinics.
39(1):71-85
[DOI] 10.1016/j.ncl.2020.09.004.
[PMID] 33223090.
2021
An Update on Botulinum Toxin in Neurology.
Neurologic clinics.
39(1):209-229
[DOI] 10.1016/j.ncl.2020.09.014.
[PMID] 33223084.
2021
Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technology
Expert Review of Medical Devices.
18(9):875-891
[DOI] 10.1080/17434440.2021.1962286.
2021
Disparities in diagnosis, treatment and survival between Black and White Parkinson patients
Parkinsonism & Related Disorders.
87:7-12
[DOI] 10.1016/j.parkreldis.2021.04.013.
2020
Co-occurrence of apathy and impulse control disorders in Parkinson disease.
Neurology.
95(20):e2769-e2780
[DOI] 10.1212/WNL.0000000000010965.
[PMID] 33004605.
2020
Current Management and Emerging Therapies in Multiple System Atrophy.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.
17(4):1582-1602
[DOI] 10.1007/s13311-020-00890-x.
[PMID] 32767032.
2020
Deep Brain Stimulation Impedance Decreases Over Time Even When Stimulation Settings Are Held Constant.
Frontiers in human neuroscience.
14
[DOI] 10.3389/fnhum.2020.584005.
[PMID] 33240066.
2020
Functional and Structural Connectivity Patterns Associated with Clinical Outcomes in Deep Brain Stimulation of the Globus Pallidus Internus for Generalized Dystonia
American Journal of Neuroradiology.
41(3):508-514
[DOI] 10.3174/ajnr.a6429.
2020
High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy.
Tremor and other hyperkinetic movements (New York, N.Y.).
10
[DOI] 10.7916/tohm.v0.749.
[PMID] 32149014.
2020
Neuroimaging Advances in Deep Brain Stimulation: Review of Indications, Anatomy, and Brain Connectomics
American Journal of Neuroradiology.
41(9):1558-1568
[DOI] 10.3174/ajnr.a6693.
2020
Using rodent models to understand interactions between gambling and substance use.
Current opinion in behavioral sciences.
31:37-41
[DOI] 10.1016/j.cobeha.2019.10.012.
[PMID] 33102640.
2019
Dorsal GPi/GPe Stimulation Induced Dyskinesia in a Patient with Parkinson’s Disease.
Tremor and other hyperkinetic movements (New York, N.Y.).
9
[DOI] 10.7916/tohm.v0.685.
[PMID] 31565536.
2015
Calcinosis cutis presenting in the context of long-term therapy for chronic myeloid leukemia: a case report and review of the literature.
Wounds : a compendium of clinical research and practice.
27(2):20-5
[PMID] 25785904.
2011
Microtubule-severing ATPase spastin in glioblastoma: increased expression in human glioblastoma cell lines and inverse roles in cell motility and proliferation.
Journal of neuropathology and experimental neurology.
70(9):811-26
[DOI] 10.1097/NEN.0b013e31822c256d.
[PMID] 21865889.
Grants
Mar 2022
ACTIVE
Assessment of diffusion imaging metrics in cerebellar tracts as a quantitative marker of disease progression in SCA
Role: Principal Investigator
Funding: NATL ATAXIA FOUNDATION
Jul 2021
ACTIVE
Cognitive and Motivational Network Dysfunction & Neuromodulation in Aging and Synucleinopathy
Role: Principal Investigator
Funding: UF FOUNDATION
Jul 2021
– Dec 2022
Cognitive and Motivational Network Dysfunction & Neuromodulation in Aging and Synucleinopathy
Role: Principal Investigator
Funding: UF FOUNDATION
Jul 2021
– Jul 2021
Optogenetic Modulation of Mesocorticolimbic Brain Networks as a Treatment for Parkinsons Disease Cognitive Dysfunction
Role: Principal Investigator
Funding: AMER ACAD OF NEUROLOGY
May 2021
ACTIVE
Cognitive and Affective Network Dysfunction and Neuromodulation in Aging and Synucleinopathy
Role: Principal Investigator
Funding: NATL INST OF HLTH NIA
Jan 2020
– Jun 2021
Modulation of Synuclein Pathology Through Induction of Gamma Band Oscillations in a Mouse Model of DLB
Role: Principal Investigator
Funding: UF FOUNDATION
Jun 2019
– May 2021
DRPD-ROF2019: A Microfluidics Optrode: A Next Generation Approach to Brain Network Modulation in Parkinsons Disease
Role: Principal Investigator
Funding: UF RESEARCH
Education
Fellowship, Movement Disorders
2018
·
University of Florida
Residency, Neurology
2015-2018
·
University of Chicago Medical Center
Doctorate Degree, Philosophy and Neuroscience
2007-2012
·
University of Illinois College of Medicine at Chicago
Medical Degree
2005-2012
·
University of Illinois College of Medicine at Chicago
Bachelor of Arts, Physics and Religion
1996-2001
·
Oberlin College
Contact Details
Phones:
- Business:
- (352) 294-5000
Emails:
- Business:
- mburns1@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100236
GAINESVILLE IL 32610 - Business Street:
-
1149 NEWELL DR RM L2 # 140
GAINESVILLE FL 32610